Tuning T cell activation threshold and effector function with cross-reactive peptide ligands

International Immunology

Volumn 12, Issue 2, 2000, Pages 205-213

  Nicholson, Lindsay B ^a   Anderson, Ana C ^a   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Superagonists; T cell tuning; TCR cross reactivity

Indexed keywords

CD4 ANTIGEN; CROSS REACTING ANTIGEN; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CROSS REACTION; CYTOKINE RELEASE; FEMALE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033966723     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.2.205     Document Type: Article

References (32)

1. Jorgensen, J. L., Reay, P. A., Ehrlich, E. W. and Davis, M. M. 1992. Molecular components of T-cell recognition. Annu. Rev. Immunol. 10:835.
2. Bevan, M. J. 1997. In thymic selection, peptide diversity gives and takes away. Immunity 7:175.
3. Kersh, G. J. and Allen, P. M. 1996. Essential flexibility in the T-cell antigen recognition of antigen. Nature 380:495.
4. Hemmer, B., Fleckenstein, B. T., Vergelli, M., Jung, G., McFarland, H. F., Martin, R. and Wiesmuller, K. H. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651.
5. Nicholson, L. B. and Kuchroo, V. K. 1997. T cell recognition of self and altered self antigens. Crit. Rev. Immunol. 17:449.
6. Nicholson, L. B., Waldner, H.-P., Carrizosa, A., Sette, A., Collins, M. and Kuchroo, V. K. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: Implications for autoimmunity. Proc. Natl Acad. Sci. USA 95:264.
7. De Magistris, M. T., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F. C. A., Grey, H. M. and Sette, A. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
8. h cell proliferation by an altered T cell receptor ligand. Science 252:1308.
9. Evavold, B. D., Sloan-Lancaster, J. and Allen, P. M. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.
10. Racioppi, L., Ronchese, F., Matis, L. A. and Germain, R. N. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
11. Sloan-Lancaster, J., Evavold, B. D. and Allen, P. M. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
12. Allen, P. M. 1994. Peptides in positive and negative selection: a delicate balance. Cell 76:593.
13. Jameson, S. C. and Sevan, M. J. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1.
14. Janeway, C. A. and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
15. Germain, R. N. and Stefanova, I. 1999. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu. Rev. Immunol. 17:467.
16. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. A. and Kuchroo, V. K. 1995. An altered peptide ligand mediates immune deviation and prevents experimental autoimmune encephalomyelitis. Immunity 3:397.
17. Wraith, D. C., McDevitt H. O., Steinman, L. and Acha-Orbea, H. 1989. T cell recognition as the target for immune intervention in autoimmune disease. Cell 57:709.
18. Carrizosa, A. M., Nicholson, L. B., Farzan, M., Southwood, S., Sette, A., Sobel, R. A. and Kuchroo V. K. 1998. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J. Immunol. 161:3307.
19. Ufretvincenty, R. L., Quigley, L., Tresser, N., Pak, S. H., Gado, A., Hausmann, S., Wucherpfennig, K. W. and Brocke, S. 1998. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J. Exp. Med. 188:1725.
20. β usage. J. Immunol. 148:3776.
21. Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V., Davis, K., Murphy, K. M. and O'Garra, A. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901.
22. Grossman, Z. and Paul, W. E. 1992. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl Acad. Sci. USA 89:10365.
23. Grossman, Z. and Singer, A. 1996. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc. Natl Acad. Sci. USA 93:14747.
24. Lucas, B., Stefanova, I., Yasutomo, K., Dautigny, N. and Germain, R. N. 1999. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity 10:367.
25. Hsu, B. L., Evavold, B. D. and Allen, P. M. 1995. Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181:805.
26. Vidal, K., Hsu, B. L., Williams, C. B. and Allen, P. M. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311.
27. Beverley, P. C. L. 1990. Is T-cell memory maintained by crossreactive stimulation? Immunol. Today 11:203.
28. Nicholson, L. B., Carrizosa, A. M. and Kuchroo, V. K. 1998. Pathogenic versus protective repertoires in autoimmune disease: Tuning the balance. Immunologist 6:151.
29. Hampl, J., Chien, Y. H. and Davis, M. M. 1997. CD4 augments the response of a T cell to agonist but not antagonist ligands. Immunity 7:379.
30. Madrenas, J., Chau, L. A., Smith, J., Bluestone, J. A. and Germain, R. N. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219.
31. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
32. Van Parijs, L. and Abbas, A. 1998. Homeostasis and self-tolerance in the immune system - turning lymphocytes off. Science 280:243.